Psychiatry and Neurology, Neurology · Hershey, PA
NPI
1912955907
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
500 University Dr
Hershey, PA, 17033
Phone (800) 233-4082
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
287 services
Medicare patients, 2024
151
Average age 68
Drug cost, 2024
$4.0M
1,506 prescriptions
Company payments, 2025
$17
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary A Thomas was code 99214 (office e&m - established), 60 times for 46 patients. In total Gary A Thomas billed 287 services in 20 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 60 | 46 | $64.00 | $3,840 |
| 99214 Office E&M - Established | Office | 41 | 35 | $67.49 | $2,767 |
| 99231 Hospital E&M - Subsequent | Facility | 33 | 13 | $37.24 | $1,229 |
| 95886 Electrical Nerve Conductivity | Facility | 29 | 18 | $28.90 | $838 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 15 | $59.91 | $1,558 |
| 99213 Office E&M - Established | Office | 14 | 12 | $41.51 | $581 |
| 99213 Office E&M - Established | Facility | 13 | 13 | $48.09 | $625 |
By year: 2022 $18K for 308 services; 2023 $18K for 318 services; 2024 $16K for 287 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gary A Thomas prescribed most often to Medicare patients was Baclofen, with 170 prescriptions and refills. In total Gary A Thomas wrote 1,506 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 170 | 430 | 51 | $5,686 |
| Dalfampridine Er Dalfampridine | 132 | 206 | 27 | $51K |
| Copaxone Glatiramer Acetate | 109 | 137 | 16 | $815K |
| Gabapentin Generic | 100 | 267 | 34 | $2,232 |
| Teriflunomide Generic | 81 | 93 | 13 | $4,874 |
| Vumerity Diroximel Fumarate | 53 | 53 | Under 11 | $460K |
| Dimethyl Fumarate Generic | 42 | 56 | Under 11 | $118K |
| Topiramate Generic | 38 | 96 | 14 | $225 |
| Pantoprazole Sodium Generic | 32 | 68 | Under 11 | $313 |
| Modafinil Generic | 32 | 82 | 12 | $4,087 |
| Aubagio Teriflunomide | 32 | 72 | Under 11 | $642K |
| Levetiracetam Generic | 26 | 48 | Under 11 | $784 |
| Tecfidera Dimethyl Fumarate | 26 | 26 | Under 11 | $241K |
| Trazodone Hcl Generic | 24 | 71 | Under 11 | $327 |
| Zonisamide Generic | 23 | 59 | Under 11 | $1,591 |
Brand drugs: 319 claims; generic drugs: 1,187 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary A Thomas $17 ($17 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $17.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.